Colgate-Palmolive Co
NYSE:CL
Intrinsic Value
Colgate-Palmolive Co. is engaged in the manufacturing and distribution of consumer products. [ Read More ]
The intrinsic value of one CL stock under the Base Case scenario is 68.58 USD. Compared to the current market price of 88.98 USD, Colgate-Palmolive Co is Overvalued by 23%.
Valuation Backtest
Colgate-Palmolive Co
Run backtest to discover the historical profit from buying and selling CL stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Colgate-Palmolive Co
Current Assets | 5.3B |
Cash & Short-Term Investments | 1.1B |
Receivables | 1.6B |
Other Current Assets | 2.5B |
Non-Current Assets | 11.1B |
PP&E | 4.6B |
Intangibles | 5.3B |
Other Non-Current Assets | 1.2B |
Current Liabilities | 4.7B |
Accounts Payable | 1.7B |
Accrued Liabilities | 2.4B |
Short-Term Debt | 310m |
Other Current Liabilities | 356m |
Non-Current Liabilities | 11B |
Long-Term Debt | 8.2B |
Other Non-Current Liabilities | 2.8B |
Earnings Waterfall
Colgate-Palmolive Co
Revenue
|
19.5B
USD
|
Cost of Revenue
|
-8.1B
USD
|
Gross Profit
|
11.3B
USD
|
Operating Expenses
|
-7.3B
USD
|
Operating Income
|
4B
USD
|
Other Expenses
|
-1.7B
USD
|
Net Income
|
2.3B
USD
|
Free Cash Flow Analysis
Colgate-Palmolive Co
CL Profitability Score
Profitability Due Diligence
Colgate-Palmolive Co's profitability score is 69/100. The higher the profitability score, the more profitable the company is.
Score
Colgate-Palmolive Co's profitability score is 69/100. The higher the profitability score, the more profitable the company is.
CL Solvency Score
Solvency Due Diligence
Colgate-Palmolive Co's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Score
Colgate-Palmolive Co's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CL Price Targets Summary
Colgate-Palmolive Co
According to Wall Street analysts, the average 1-year price target for CL is 92.67 USD with a low forecast of 70.7 USD and a high forecast of 108.15 USD.
Ownership
CL Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
CL Price
Colgate-Palmolive Co
Average Annual Return | 6.32% |
Standard Deviation of Annual Returns | 13.9% |
Max Drawdown | -23% |
Market Capitalization | 72.8B USD |
Shares Outstanding | 821 985 984 |
Percentage of Shares Shorted | 1.43% |
CL News
Last Important Events
Colgate-Palmolive Co
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Colgate-Palmolive Co
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Colgate-Palmolive Co. is engaged in the manufacturing and distribution of consumer products. The company is headquartered in New York City, New York and currently employs 33,800 full-time employees. The firm operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. The firm is also engaged in various product categories of the personal care market with operations in liquid hand soap, which it sells under the Palmolive, Protex and Softsoap brands. Its Personal Care products also include bar soaps, shower gels, deodorants, antiperspirants, and shampoos and conditioners. Colgate manufactures and markets a range of products for the home care market, including Ajax, Axion and Palmolive dishwashing liquids and Ajax, Fabuloso and Murphy household cleaners. The Company, through its Hill's Pet Nutrition segment (Hill's), manufactures pet nutrition products for dogs and cats.
Contact
IPO
Employees
Officers
The intrinsic value of one CL stock under the Base Case scenario is 68.58 USD.
Compared to the current market price of 88.98 USD, Colgate-Palmolive Co is Overvalued by 23%.